Author:
Takakura Aya,Sato Takanori,Lee Ji-Won,Hirano Kyoko,Takao-Kawabata Ryoko,Ishizuya Toshinori,Iimura Tadahiro
Abstract
AbstractOsteoporosis is an age-related disorder that is characterized by reduced bone mass. Its prevention and treatment are important healthcare issues for maintaining social activity in aged societies. Although bone fractures mostly occur at sites of weakened cortical bone, pathophysiological and pharmacological evaluations of bone mass have tended to be predominantly assessed in trabecular bone. To statistically characterize cortical bone remodeling, we originally established multimode fluorescence imaging and artificial intelligence (AI)-driven morphometric analyses in six-month-old female rabbits with well-defined cortical remodeling, similar to that in humans. We evaluated three distinct administration frequencies of teriparatide [TPTD; human parathyroid hormone, hPTH (1–34)]: once (1/w), twice (2/w), and seven times (7/w) a week, with the same total dose (140 μg/kg/week). Our analyses revealed significant expansions of the osteocytic lacunar-canalicular system and Haversian canals accompanied by the development of cortical porosity and endosteal naïve bone formation induced by a frequent administration regimen (7/w) of TPTD; however, once-weekly (1/w) and twice-weekly (2/w) administration of TPTD showed little effect. These findings demonstrate a clear contrast between the effects of frequent and infrequent administration of TPTD on cortical bone metabolism and suggest that osteocytic bone remodeling is involved in the pharmacological action of PTH.
Publisher
Springer Science and Business Media LLC
Reference52 articles.
1. NIH Consensus Development Panel on Osteoporosis Prevention. Diagnosis, and Therapy, March 7–29, 2000: highlights of the conference. South Med. J. 94, 569–573 (2001).
2. Cooper, D. M., Kawalilak, C. E., Harrison, K., Johnston, B. D. & Johnston, J. D. Cortical bone porosity: What is it, why is it important, and how can we detect it?. Curr. Osteoporos. Rep. 14, 187–198. https://doi.org/10.1007/s11914-016-0319-y (2016).
3. Harrison, K. D. & Cooper, D. M. Modalities for visualization of cortical bone remodeling: The past, present, and future. Front Endocrinol (Lausanne) 6, 122. https://doi.org/10.3389/fendo.2015.00122 (2015).
4. Harrison, K. D. et al. Cortical bone porosity in rabbit models of osteoporosis. J. Bone Miner Res. 35, 2211–2228. https://doi.org/10.1002/jbmr.4124 (2020).
5. Diab, T., Condon, K. W., Burr, D. B. & Vashishth, D. Age-related change in the damage morphology of human cortical bone and its role in bone fragility. Bone 38, 427–431. https://doi.org/10.1016/j.bone.2005.09.002 (2006).